204 related articles for article (PubMed ID: 12917766)
21. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
22. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].
Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH
Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.
Friess H; Lu Z; Riesle E; Uhl W; Bründler AM; Horvath L; Gold LI; Korc M; Büchler MW
Ann Surg; 1998 Jan; 227(1):95-104. PubMed ID: 9445116
[TBL] [Abstract][Full Text] [Related]
24. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
Terada T; Nakanuma Y
Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
[TBL] [Abstract][Full Text] [Related]
25. Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
Chijiiwa K; Ichimiya H; Kuroki S; Koga A; Nakayama F
Surg Gynecol Obstet; 1993 Sep; 177(3):279-82. PubMed ID: 8395085
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.
Zen Y; Harada K; Sasaki M; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
Lab Invest; 2005 Apr; 85(4):572-81. PubMed ID: 15696189
[TBL] [Abstract][Full Text] [Related]
27. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
28. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
29. The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.
Puthdee N; Sriswasdi S; Pisitkun T; Ratanasirintrawoot S; Israsena N; Tangkijvanich P
Cancer Gene Ther; 2022 May; 29(5):445-455. PubMed ID: 34548635
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
[TBL] [Abstract][Full Text] [Related]
31. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
32. Decrease of deleted in malignant brain tumour-1 (DMBT-1) expression is a crucial late event in intrahepatic cholangiocarcinoma.
Sasaki M; Huang SF; Chen MF; Jan YY; Yeh TS; Ishikawa A; Mollenhauer J; Poustka A; Tsuneyama K; Nimura Y; Oda K; Nakanuma Y
Histopathology; 2003 Oct; 43(4):340-6. PubMed ID: 14511252
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma.
Sasaki M; Tsuneyama K; Nakanuma Y
Lab Invest; 2003 Oct; 83(10):1403-13. PubMed ID: 14563942
[TBL] [Abstract][Full Text] [Related]
35. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
[TBL] [Abstract][Full Text] [Related]
36. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
37. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas.
Schmid P; Itin P; Rufli T
Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422
[TBL] [Abstract][Full Text] [Related]
38. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.
Kim HJ; Kim JS; Suh SJ; Lee BJ; Park JJ; Lee HS; Kim CD; Bak YT
World J Surg; 2015 Jun; 39(6):1537-42. PubMed ID: 25648078
[TBL] [Abstract][Full Text] [Related]
39. [Distribution and expression of transforming growth factor beta and their receptors in hypertrophic scar].
Lu L; Chen YL; Zhang QG
Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):30-3. PubMed ID: 15059449
[TBL] [Abstract][Full Text] [Related]
40. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
Minato H; Nakanuma Y; Terada T
Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]